Health Care · Services-Offices & Clinics of Doctors of Medicine · Nasdaq · CIK 1870940 · FYE Dec 31 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $4.66Day −0.64%Mkt cap $329M1Y −26.5%Off 52W high −61.2%Vol (1Y) 118.2%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,184 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest4.4% of sh out |
| Days to cover7.8d |
| 13F net flow (QoQ)+1.16% |
| Top-10 13F concentration90.5% |
| Next report (est.)2026-08-07 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$151.8M |
| Earnings (TTM)-$11.2M |
| ROE−14.1% |
| Net margin−7.7% |
| ROIC−6.6% |
| Debt / equity0.64× |
| Total debt / EBITDA45.90× |
| Sales growth 3Y−3.5% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+135.4% |
| 1Y−26.5% |
| 3Y−46.7% |
| Since incept. (ann.)−21.2% |
Total return through 2026-07-28 · series begins 2021-11-02. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)118.2% |
| Ann. volatility (3Y)96.8% |
| Sharpe (1Y)0.33 |
| Sharpe (3Y)0.27 |
| Max drawdown (1Y)−86.4% |
| Max drawdown (3Y)−86.4% |
| Beta (3Y vs SPY)2.70 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Vesey Street Capital Partners, L.L.C. | 30.3M | $86M | 42.99% | +0.0% |
| Balyasny Asset Management L.P. | 2.3M | $7M | 3.30% | +32.9% |
| FourWorld Capital Management LLC | 987,757 | $3M | 1.40% | +105.7% |
| BlackRock, Inc. | 804,079 | $2M | 1.14% | −17.5% |
| WEXFORD CAPITAL LP | 670,517 | $2M | 0.95% | +0.1% |
| UBS Group AG | 622,292 | $2M | 0.88% | +396.4% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 474,445 | $1M | 0.67% | new |
| GEODE CAPITAL MANAGEMENT, LLC | 368,456 | $1M | 0.52% | −8.6% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-08 | −$0.03 | — | $39.4M | +0.0% |
| 2025-12-31 | 2026-03-16 | — | — | $33.4M | −14.6% |
| 2025-09-30 | 2025-11-07 | −$0.15 | — | $35.0M | −17.8% |
| 2025-06-30 | 2025-08-01 | −$0.01 | — | $44.0M | −13.7% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-07 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
Reportable 100%
business segments · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
